Predictive value of the Leuven HRD test compared with Myriad myChoice PLUS on 468 ovarian cancer samples from the PAOLA-1/ENGOT-ov25 trial (LBA 6)
Liselore Loverix,
Ignace Vergote,
Pieter Busschaert,
Adriaan Vanderstichele,
Bram Boeckx,
Tom Venken,
Philipp Harter,
Hilde Brems,
Els Van Nieuwenhuysen,
Sandro Pignata,
Gynecologic Oncology · 2022 · 23 citations · 0 references